| Literature DB >> 35743574 |
Anton Straub1, Roman Brands1, Anna Borgmann1, Andreas Vollmer1, Julian Hohm1, Christian Linz1, Urs Müller-Richter1,2,3, Alexander C Kübler1, Stefan Hartmann1.
Abstract
Reconstruction of the donor site after radial forearm flap harvesting is a common procedure in maxillofacial plastic surgery. It is normally carried out with split-thickness or full-thickness free skin grafts. Unfortunately, free skin graft transplantation faces wound healing impairments such as necrosis, (partial) graft loss, or tendon exposure. Several studies have investigated methods to reduce these impairments and demonstrated improvements if the wound bed is optimised, for example, through negative-pressure wound therapy or vacuum-assisted closure. However, these methods are device-dependent, expansive, and time-consuming. Therefore, the application of platelet-rich fibrin (PRF) to the wound bed could be a simple, cost-effective, and device-independent method to optimise wound-bed conditions instead. In this study, PRF membranes were applied between the wound bed and skin graft. Results of this study indicate improvements in the PRF versus non-PRF group (93.44% versus 86.96% graft survival, p = 0.0292). PRF applied to the wound bed increases graft survival and reduces impairments. A possible explanation for this is the release of growth factors, which stimulate angiogenesis and fibroblast migration. Furthermore, the solid PRF membranes act as a mechanical barrier ("lubrication" layer) to protect the skin graft from tendon motion. The results of this study support the application of PRF in donor-site reconstruction with free skin grafts.Entities:
Keywords: donor-site morbidity; free skin grafts; platelet-rich fibrin; radial forearm flap
Year: 2022 PMID: 35743574 PMCID: PMC9225102 DOI: 10.3390/jcm11123506
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Flowchart depicting patient selection and study design.
Figure 2(1) Illustrates the defect on the forearm after radial forearm flap harvest. (2) Wound bed and tendons were covered with PRF membranes. (3) Full-thickness free skin graft from the ipsilateral arm was placed on the PRF membranes. (4) Pressure bandage was applied and followed by sterile dressing.
Figure 3The left image depicts the photographic documentation after removal of the pressure bandage ten days after skin graft transplantation. On the (right) image, the surface area and area of dehiscence and necrosis were determined with the ImageJ software and with the help of the scale bar see (left) image. In the presented example, the area of the donor site was determined as being 20.320 cm2 and the area of graft loss as 1.578 cm2 (1.346 cm2 + 0.232 cm2). This led to a calculated coverage rate of 92.23% and a corresponding dehiscence rate of 7.77%.
Evaluation score.
| Yes | No | ||
|---|---|---|---|
| Total score | 0–6 | ||
| Infection | 1 | 0 | |
| Inflammation | 1 | 0 | |
| Necrosis | 1 | 0 | |
| Visible tendon * | 1 | 0 | |
| Tendon exposure * | 1 | 0 | |
| Transplant loss > 10% | 1 | 0 | |
| Total transplant loss ** | 6 | 0 |
* “Visible tendon” was defined as tendons of the hand being seen through the skin graft as a predictor of graft loss in this area. “Tendon exposure”, in contrast, indicated dehiscence of the graft above the tendons. ** “Total transplant” loss was defined as critical point. The occurrence of this event scored the maximum number of points (6).
Descriptive statistics.
| PRF+ | PRF− | |
|---|---|---|
| Age (±SD) | 63.50 ± 18.04 | 62.38 ± 20.49 |
| Participants ( | 16 | 16 |
| Gender | ||
| Women | 5 | 6 |
| Men | 11 | 10 |
| Diagnosis | ||
| Oral cancer | 12 | 16 |
| Skin cancer | 4 | 0 |
| Graft size (cm2; ±SD) | 19.5 ± 9.14 | 18.4 ± 5.95 |
| Skin graft ( | ||
| Full-thickness | 6 | 12 |
| Split-thickness | 10 | 4 |
| Reconstruction | ||
| Primary | 4 | 13 |
| Secondary | 12 | 3 |
| Intravenous antibiotics | ||
| No antibiotic therapy | 5 | 2 |
| Ampicillin/sulbactam | 11 | 13 |
| Clindamycin | 0 | 1 |
Effect of intravenous antibiotics on the healing rate.
| Patients | Dehiscence in % | Infections | ||
|---|---|---|---|---|
| Intravenous antibiosis | 0.3888 * | |||
| None | 7 | 7.16 | 0 | |
| Ampicillin/sulbactam | 25 | 10.77 | 1 | |
| or clindamycin |
Twenty-five patients underwent intravenous antibiosis (ampicillin/sulbactam or clindamycin in case of allergies), and the remaining seven patients did not undergo antibiosis. * There was no difference between the two groups regarding the occurrence of dehiscence and infection.
Dehiscence: PRF vs. non-PRF.
| M (±SD) in % | Md | Range | 95% CI | ||
|---|---|---|---|---|---|
| Coverage rate | |||||
| PRF+ | 93.44 ± 5.212 | 94.73 | 80.92–100 | ||
| PRF− | 86.96 ± 12.10 | 89.26 | 54.81–100 | ||
| Difference | 6.483 ± 3294 | 0.0292 | −0.2450–13.21 |
* Statistical significance for p < 0.05.
Figure 4Coverage rate in percent in the PRF and non-PRF groups.
Detailed comparison of the evaluation scores in the PRF and non-PRF groups.
| PRF | Non-PRF | Difference | ||
|---|---|---|---|---|
| Mean total score | 1.5 | 2.688 | 1.188 | 0.0458 |
| Infection | 0 | 1 | 1 | 0.1627 |
| Inflammation | 0 | 2 | 2 | 0.0768 |
| Necrosis | 7 | 9 | 2 | 0.2477 |
| Visible tendon | 3 | 4 | 1 | 0.3405 |
| Tendon exposure | 2 | 4 | 2 | 0.1907 |
| >10% dehiscence | 2 | 8 | 6 | 0.0108 |
Table 5 depicts the number of “yes” answers in each category. A higher evaluation score indicated a negative surgical result. The results were generally better in PRF group than in non-PRF group, but failed to be statistically significant apart from the item “>10% dehiscence”.
Figure 5Evaluation score in the PRF group and in the non-PRF group.